Hiratsuka, Daiki
Omura, Erika
Ishizawa, Chihiro
Iida, Rei
Fukui, Yamato
Hiraoka, Takehiro
Akaeda, Shun
Matsuo, Mitsunori
Harada, Miyuki
Wada-Hiraike, Osamu
Osuga, Yutaka
Hirota, Yasushi
Funding for this research was provided by:
Japan Society for the Promotion of Science (JP22K16852, 23K15827, JP22H03222 and JP22K19596, JP22H02538 and JP22K19595)
Ministry of Health, Labour and Welfare (JPMH21DA2002 and JPMH21DA1003)
Japan Agency for Medical Research and Development (JP23gk0210028 and JP23gk0110056, JP23lk0310083 and JP23gk0110069)
Article History
Received: 31 December 2022
Accepted: 26 August 2023
First Online: 4 September 2023
Declarations
:
: The authors declare no competing interests.
: This study was performed in accordance with the Declaration of Helsinki and the Ethical Guidelines for Medical and Biological Research Involving Human Subjects formulated by the Japanese government. This study was reviewed and approved by the Research Ethics Committee of the Faculty of Medicine of the University of Tokyo (IRB number: 3128). Informed written consent was substituted by the informed opt-out procedure because of the retrospective nature of the study. The information about this study was posted on the website of the University of Tokyo Hospital to give participants the opportunity to opt out, and those who did not opt out were considered to have provided tacit consent for study participation. Anonymous clinical data were used for the analysis, and individuals cannot be identified based on the data presented. The waived written consent and the informed opt-out procedure were approved by the Research Ethics Committee of the Faculty of Medicine of the University of Tokyo.
: Not applicable.